Although the mechanism of action of the sympathomimetics in the treatment of obesity is not fully known, these medications have pharmacological effects similar to those of amphetamines. Like other sympathomimetic appetite suppressants, mazindol is thought to act as a [[Norepinephrine reuptake inhibitor|reuptake inhibitor]] of [[norepinephrine]]. In addition, it inhibits [[dopamine]] and [[serotonin]] [[reuptake]]. The recommended dosage is 2&nbsp;mg per day for 90 days in patients 40&nbsp;kg overweight and under; 4&nbsp;mg a day in patients more than 50&nbsp;kg overweight; separated into two doses separated by a 12-hour window between each 2&nbsp;mg dose.
